AVIEW LCS vs vascuCAP
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are adjacent in their application of AI to CT imaging for cardiovascular assessment. AVIEW LCS offers a broader scope, combining lung cancer screening with basic coronary artery calcification scoring. In contrast, vascuCAP specializes in detailed, histologically-validated quantification of arterial plaque composition for advanced cardiovascular risk stratification.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
AVIEW LCS is primarily an AI-powered solution for the detection and analysis of lung nodules, lung cancer screening, COPD, and coronary artery calcification from a single low-dose CT scan. vascuCAP (now ElucidVivo/PlaqueIQ) is an AI software focused on non-invasive CT angiography analysis to quantify plaque composition and assess cardiovascular risk for optimizing treatment decisions.
AVIEW LCS performs its integrated analysis of lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan. vascuCAP analyzes routinely available non-invasive CT angiograms to characterize plaque tissues.
AVIEW LCS provides Coronary Artery Calcification (CAC) scoring, including Agatston, volume, and mass scores. In contrast, vascuCAP offers histologically-validated plaque quantification and characterization, detailing lipid-rich necrotic core, calcification, non-calcified matrix, and intraplaque hemorrhage, along with risk stratification for stroke and heart attack.
AVIEW LCS provides automated lung nodule detection and analysis, Lung-RADS classification and reporting, nodule volume quantification and 3D segmentation, and emphysema quantification (LAA index). vascuCAP quantifies specific plaque components like lipid-rich necrotic core, calcification, non-calcified matrix, and intraplaque hemorrhage, and offers 3D visualization of arterial vessels and plaque.
AVIEW LCS is designed for Cardiology, Oncology, Pulmonology, and Radiology specialties, focusing on cardiopulmonary assessment. vascuCAP is intended for Cardiology, Radiology, and Vascular Surgery, with a focus on cardiovascular diagnostic imaging and plaque assessment.